2021
The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis
Tan W, Xu D, Xu M, Wang Z, Dai B, Li L, Zhao H, Wang W, Kang J. The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis. Therapeutic Advances In Respiratory Disease 2021, 15: 17534666211009407. PMID: 33888007, PMCID: PMC8071979, DOI: 10.1177/17534666211009407.Peer-Reviewed Original ResearchConceptsAcute hypoxemic respiratory failureAcute respiratory distress syndromeNon-invasive respiratory supportHypoxemic respiratory failureNon-intubated patientsNon-invasive ventilationRandomized controlled trialsNon-COVID-19 patientsCOVID-19 patientsRespiratory failureRespiratory supportIntubation rateReduced respiratory rateHigh-flow nasal oxygen therapyMortality rateNewcastle-Ottawa Quality Assessment ScaleMeta-analysisNasal oxygen therapyRespiratory distress syndromeNon-COVID-19Supplemental material sectionCochrane Central RegisterQuality Assessment ScaleLong durationRandom-effects model
2010
[Risk factors of novel severe influenza A(H1N1) with concurrent adult respiratory distress syndrome].
Dai B, Kang J, Wang Z, Kong D, Tan W, Zhao H. [Risk factors of novel severe influenza A(H1N1) with concurrent adult respiratory distress syndrome]. National Medical Journal Of China 2010, 90: 2392-5. PMID: 21092507.Peer-Reviewed Original ResearchConceptsAdult respiratory distress syndromeT lymphocyte subsetsSevere influenza AMultivariate logistic regression analysisNon-ARDS groupInfluenza ANon-smoking groupLogistic regression analysisStatistically significant differenceRisk factorsIncidence of adult respiratory distress syndromeAdult respiratory distress syndrome patientsNovel influenza APatient lymphocyte countsRespiratory distress syndromeSignificant differenceControlled clinical trialsLactate dehydrogenaseRegression analysisDistress syndromeLymphocyte countClinical featuresRetrospective analysisClinical trialsH1N1